SCHEMBL5322113

SCHEMBL5322113

COC(=O)CCCC(NC(=O)c1ccc(NCc2cnc3nc(N)nc(N)c3n2)c(C)c1)C(=O)OC

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 7/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5323442 0.86 DHFR (0.58) DHFR
SCHEMBL15056149 0.83 DHFR (0.82) DHFR
SCHEMBL15056153 0.83 DHFR (0.82) DHFR
SCHEMBL8444708 0.79 DHFR (0.49) DHFR
SCHEMBL24344803 0.79 DHFR (0.52) DHFR
SCHEMBL7253914 0.78 DHFR (0.47) DHFR
SCHEMBL20286623 0.78 DHFR (0.72) DHFR
SCHEMBL8420248 0.77 DHFR (0.47) DHFR
SCHEMBL19918327 0.76 DHFR (0.76) DHFR
SCHEMBL16546067 0.76 DHFR (0.76) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007098089-A2 TREATMENT OF HYPERPROLIFERATIVE DISEASES WITH METHOTREXATE N-OXIDE AND ANALOGS NOVACEA, INC. (US) 2007-08-30 — — WO claimed
Send feedback